Brief: Enlivex Israeli Ministry Of Health Authorizes Initiation Of Phase IIb Clinical Trial Evaluating Safety And Efficacy Of Allocetra In Sepsis Patients
03/11/2020 14:14
Nov 3 (Reuters) - Enlivex Therapeutics Ltd ENLV.TA :
* ENLIVEX: ISRAELI MINISTRY OF HEALTH AUTHORIZES INITIATION
OF
PHASE IIB CLINICAL TRIAL EVALUATING SAFETY AND EFFICACY OF
ALLOCETRA IN SEPSIS PATIENTS
Source text for Eikon: ID:nGNX3vBYVk
Further company coverage: ENLV.TA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Enlivex
See all newsBrief: Enlivex Ltd Registers Up To 23,333,333 Ordinary Shares For Resale By Selling Shareholder
Brief: Enlivex Announces Second Regulatory Approval For Phase 2B Trial Of Allocetra In Age-Related Primary Moderate-To-Severe Knee Osteoarthritis
Brief: Enlivex Therapeutics Files For Offering Of Up To $299.6 Mln Of Ordinary Shares
Brief: Enlivex Announces Positive 6-Month Topline Data For Patients with Knee Osteoarthritis
Brief: Enlivex Files Patent for Allocetra Use in Osteoarthritis Treatment